平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體
Monoclonal Antibody to Actin Alpha 2, Smooth Muscle (ACTa2)
ACT-A2; ACTSA; ACTVS; Asma; GIG46; Cell growth-inhibiting gene 46 protein
- 編號(hào)MAB342Hu22
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(jià)(克隆號(hào))D2
- Ig亞型 IgG2a Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPB342Hu01-平滑肌肌動(dòng)蛋白α2(ACTa2)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度1mg/ml
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 738 ¥ 1722 ¥ 2460 ¥ 6150 ¥ 24600
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Western Blot; Sample: Rat Skeletal muscle lysate Primary Ab: 2μg/ml Mouse Anti-Human ACTa2 Antibody Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
Western Blot; Samples: Lane1: Mouse Heart lysate; Lane2: Mouse Skeletal muscle lysate;
Primary Ab: 2μg/ml Mouse Anti-Human ACTa2 Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對(duì)ACTa2的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別ACTa2。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB342Hu01 | 平滑肌肌動(dòng)蛋白α2(ACTa2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB342Hu02 | 平滑肌肌動(dòng)蛋白α2(ACTa2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| CPB342Hu21 | 平滑肌肌動(dòng)蛋白α2(ACTa2)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
| PAB342Hu01 | 平滑肌肌動(dòng)蛋白α2(ACTa2)多克隆抗體 | WB; IHC; ICC; IP. |
| CAB342Hu01 | 抗平滑肌肌動(dòng)蛋白α2(ACTa2)多克隆抗體 | Loading Control of WB. |
| MAB342Hu22 | 平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB342Hu21 | 平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | WB; IHC; ICC; IP. |
| CAB342Hu22 | 抗平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | Loading Control of WB |
| MAB342Hu29 | 平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB342Hu23 | 平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB342Hu24 | 平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB342Hu25 | 平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB342Hu27 | 平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | WB; IHC; ICC; IP. |
| FAB342Hu04 | 抗平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | Flow cytometry. |
| FAB342Hu02 | 抗平滑肌肌動(dòng)蛋白α2(ACTa2)單克隆抗體 | Flow cytometry. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Cell Mol Immunol? | Toxoplasma gondii GRA15II effector-induced M1 cells ameliorate liver fibrosis in mice infected with Schistosomiasis japonica [Pubmed:27157496] |
| NAUNYN-SCHMIEDEBERGS?ARCHIVES OF?PHARMACOLOGY | Effects of repeated increasing doses of cisplatin as models of acute kidney injury and chronic kidney disease in rats [Pubmed: 32936352] |
| Brazilian Journal of Pharmaceutical Sciences | Hesperidin inhibits the epithelial to mesenchymal transition induced by transforming growth factor-β1 in A549 cells through Smad signaling in the cytoplasm [] |
| Structural Changes and Detection of Liver Fibrosis¨CRelated Protein Levels in Coculture of Alveolar Echinococcosis-Protoscoleces and Human Hepatic Stellate cells [] | |
| Parasit Vectors | Structural changes and expression of hepatic fibrosis-related proteins in coculture of Echinococcus multilocularis protoscoleces and human hepatic stellate?… [34857049] |
| Clinical and Translational Medicine | NOX5 mediates the crosstalk between tumor cells and cancer‐associated fibroblasts via regulating cytokine network [34459125] |
